Combination of Distinct Vaccine Antigens

This entry represents a combination of distinct vaccine antigens used to prevent multiple infectious diseases (poliomyelitis, diphtheria, tetanus, pertussis, and hepatitis A). Poliovirus types 1/2/3 capsid proteins are the structural proteins (VP1, VP2, VP3, VP4) of the poliovirus shell, which elicit protective neutralizing antibodies. Diphtheria toxin is a protein exotoxin from Corynebacterium diphtheriae targeting eukaryotic elongation factor 2, whose toxoid form induces protective immunity. Tetanus toxin is a potent neurotoxin produced by Clostridium tetani, with its inactivated toxoid form used for vaccination. Bordetella pertussis antigens encompass several proteins/toxins (e.g., pertussis toxin, FHA, PRN, FIM), key in acellular pertussis vaccines. Hepatitis A virus capsid protein is a structural viral protein targeted by the immune system post-vaccination. Each is a well-defined vaccine target, but they are not a single molecular entity and should be recorded separately for precision in any structured database.

Induction of neutralizing and opsonizing antibodies: vaccines elicit immune responses that recognize and neutralize toxins (diphtheria, tetanus), adhere to/neutralize bacteria (B. pertussis), or block viral entry (polio, hepatitis A). Memory response: generation of long-lived memory B and T cells, primed for future exposures.